rc outsourcing, llcdrugHigh PriorityExpired

Bevacizumab 1.75 mg/0.07 mL - 0.25 mL sy... Sterility Recall

Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe has been recalled due to potential sterility concerns during manufacturing. This recall primarily affects healthcare facilities, hospitals, and pharmacies. Individual consumers are unlikely to have this product at home. Check the official FDA notice for specific lot numbers and return or disposal instructions.

By RecallRadar Editorial Team

Sourced from FDA. Last verified March 4, 2026.

On this page

Free checker

Check if you qualify

See whether your device may qualify for a free repair or replacement program before you spend money.

Check if you qualify

Key facts

Date announced: September 22, 2025
Source agency: FDA

This recall involves safety concerns. Take action promptly.

✨ Plain-English Summary

Is This Recall Still Active?

Status: No - Expired

This recall is no longer active. You can still review details here for historical reference and confirmation.

What's Being Recalled

Quoted source excerpt from the official notice.

Lack of assurance of sterility.

Quick Info

Key facts from the official notice, kept in the article flow for easy cross-checking.

Brand: Rc outsourcing, llc
Category: drug
Source agency: FDA
Announced: September 22, 2025
Country: US
Status: Expired

Who's Affected

Specific models and identifiers listed in the source notice:

Model #1

Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025

#	Model
1	Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025

Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.

What You Should Do

Follow the remedy path from the official notice using the exact model and serial details above.

1## Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH
2Agency: FDA | Category: drug Reason: Lack of assurance of sterility. What to do:
3Stop using the product if your lot/model matches.
4Check the FDA notice for specifics.

This program has ended. The official source page may no longer be available.

Source & Verification

This page summarizes the official notice and keeps key facts easy to verify.

Official source: FDA
Announced by source: September 22, 2025
Last reviewed by RecallRadar: March 4, 2026

Frequently Asked Questions

Am I affected by this recall?

Check the affected models section on this page. The official notice currently lists Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025.

What is the remedy for this recall?

## Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436. Agency: FDA | Category: drug Reason: Lack of assurance of sterility. What to do: 1. Stop using the product if your lot/model matches. 2. Check the FDA notice for specifics. 3. Follow remedy instructions.

Where can I verify recall details?

Use the official source link in this page to confirm dates, eligibility, and next steps: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Keep browsing with these internal hubs: rc outsourcing, llc recall hub and Food & Drug recall hub.